Triple
T1103709
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Leqembi |
E25439
|
entity |
| Predicate | hasRegulatoryPathway |
P14058
|
FINISHED |
| Object |
FDA traditional approval
FDA traditional approval is the U.S. Food and Drug Administration’s standard, full marketing authorization pathway granted when a drug has demonstrated substantial evidence of safety and effectiveness through adequate and well-controlled studies.
|
E125382
|
NE FINISHED |
How this triple was built (5 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: FDA traditional approval | Statement: [Leqembi, hasRegulatoryPathway, FDA traditional approval]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: FDA traditional approval Context triple: [Leqembi, hasRegulatoryPathway, FDA traditional approval]
-
A.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
B.
Federal Food, Drug, and Cosmetic Act
The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
E.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: FDA traditional approval Triple: [Leqembi, hasRegulatoryPathway, FDA traditional approval]
Generated description
FDA traditional approval is the U.S. Food and Drug Administration’s standard, full marketing authorization pathway granted when a drug has demonstrated substantial evidence of safety and effectiveness through adequate and well-controlled studies.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: FDA traditional approval Target entity description: FDA traditional approval is the U.S. Food and Drug Administration’s standard, full marketing authorization pathway granted when a drug has demonstrated substantial evidence of safety and effectiveness through adequate and well-controlled studies.
-
A.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
B.
Federal Food, Drug, and Cosmetic Act
The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
E.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasRegulatoryPathway Context triple: [Leqembi, hasRegulatoryPathway, FDA traditional approval]
-
A.
regulatoryInteraction
Indicates a relationship where one entity modulates, controls, or influences the activity, expression, or function of another entity through regulatory mechanisms.
-
B.
regulatoryType
chosen
Indicates the specific kind or category of regulatory control, rule, or oversight that applies in the given relationship.
-
C.
regulatoryOutcome
Indicates the result or consequence of a regulatory process, such as approval, rejection, modification, or other formal decision made by a regulatory authority regarding an entity or action.
-
D.
regulatesWith
Indicates that one entity controls, modulates, or influences the activity, state, or behavior of another entity through some regulatory mechanism or interaction.
-
E.
doesNotDirectlyRegulate
Indicates that one entity has no immediate or primary regulatory control or influence over another entity or process.
- F. None of above.
Provenance (6 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a49428d4448190b3b36991ceae87ce |
completed | March 1, 2026, 7:31 p.m. |
| NER | Named-entity recognition | batch_69a4b9c375848190baec4d534f489616 |
completed | March 1, 2026, 10:12 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ac4c4a402081908ee138257425a336 |
completed | March 7, 2026, 4:03 p.m. |
| NEDg | Description generation | batch_69ac4ccf989c8190aed2ff01ad6fbcab |
completed | March 7, 2026, 4:05 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69ac4d4cbed88190ac743160198493b2 |
completed | March 7, 2026, 4:07 p.m. |
| PD | Predicate disambiguation | batch_69a4b7472c848190b0643872f67084a2 |
completed | March 1, 2026, 10:01 p.m. |
Created at: March 1, 2026, 7:43 p.m.